Head-to-head · computed 2026-08-11
Direct Meds vs Willow
Direct Meds: Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery. Willow: Willow sells patient-specific 503A compounded tirzepatide at a flat $399 a month at every dose, telehealth and shipping included, in 33 states as of mid-2026 reporting.
Tirzepatide
| Direct Meds | Willow | |
|---|---|---|
| All-in maintenance | $399/mo | $399/mo |
| Best plan rate | $399/mo | $399/mo |
| 12-month total | $4,788 | $4,788 |
| Status | Reported · 2026-07-25 | Reported · 2026-08-11 |
The arithmetic
On monthly cost the two are tied at $399; the decision comes down to structure — Direct Meds's (all-inclusive per format; injection and sublingual priced separately) against Willow's (dose-flat per captured reporting: flat $399 at every dose).
Direct Meds's tirzepatide ladder runs $399 a month billed monthly. Willow's runs $399 a month billed monthly. Across a full year the two land in the same place — $4,788 — though by different routes: Direct Meds via twelve months at the month-to-month rate with no commitment, Willow via twelve months at the month-to-month rate with no commitment.
Semaglutide
Only Direct Meds offers semaglutide ($297 a month billed monthly); Willow does not, so there is no contest to score.
Where the structures genuinely differ
On dose economics, Willow is dose-flat — the price survives titration — while Direct Meds's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On verifiability, Direct Meds names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Willow's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.
Structure, side by side
Direct Meds
- MembershipNone
- Dose policyAll-inclusive per format; injection and sublingual priced separately
- CommitmentMonthly (no commitment indicated)
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
Willow
- MembershipNone
- Dose policyDose-flat per captured reporting: flat $399 at every dose
- CommitmentMonthly
- CancellationPer published terms; confirm at checkout
- PharmacyPatient-specific 503A compounding (pharmacy unnamed on captured materials)
What our desk is watching on each
Direct Meds: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
Willow: Reported from a June 15, 2026 comparison table (MenoMellow) — our own capture pending; the flat-at-every-dose structure and 33-state footprint both carry that single-source status until independently confirmed. Pharmacy unnamed on captured materials.
Questions people ask
Is Direct Meds or Willow cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Direct Meds vs Willow miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Direct Meds and Willow cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at Direct Meds and $4,788 at Willow — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Direct Meds · Willow. Official sites: Direct Meds ↗ · Willow ↗. Nothing here is medical advice.